Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 80 of 80 entries
Sorted by: Best Match Show Resources per page
Paraneoplastic microscopic polyangiitis presenting after thymectomy.

JAAD case reports

Tracey EH, Huen AO, Sreih AG, Evans T, Kobrin S, Rubin AI, Rosenbach M.
PMID: 27222874
JAAD Case Rep. 2016 Apr 16;2(2):153-5. doi: 10.1016/j.jdcr.2016.03.003. eCollection 2016 Mar.

No abstract available.

Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.

Preventive medicine

Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC.
PMID: 34762966
Prev Med. 2021 Nov 08;154:106871. doi: 10.1016/j.ypmed.2021.106871. Epub 2021 Nov 08.

Since 2012, cervical cancer screening guidelines allow for choice of screening test for women age 30-65 years (i.e., Pap every 3 years or Pap with human papillomavirus co-testing every 5 years). Intended to give patients and providers options, this...

Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome.

Ophthalmic genetics

Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, Sankila EM, Ahn J, Pyers L, Vincent A, Ferraz Sallum JM, Zein WM, Oh JK, Maldonado RS, Ryu J, Tsang SH, Gorin MB, Webster AR, Michaelides M, Yang P, Pennesi ME.
PMID: 34223797
Ophthalmic Genet. 2021 Dec;42(6):664-673. doi: 10.1080/13816810.2021.1946704. Epub 2021 Jul 05.

Atypical Usher syndrome (USH) is poorly defined with a broad clinical spectrum. Here, we characterize the clinical phenotype of disease caused by variants in

Gene-Based Association Testing of Dichotomous Traits With Generalized Functional Linear Mixed Models Using Extended Pedigrees: Applications to Age-Related Macular Degeneration.

Journal of the American Statistical Association

Jiang Y, Chiu CY, Yan Q, Chen W, Gorin MB, Conley YP, Lakhal-Chaieb ML, Cook RJ, Amos CI, Wilson AF, Bailey-Wilson JE, McMahon FJ, Vazquez AI, Yuan A, Zhong X, Xiong M, Weeks DE, Fan R.
PMID: 34321704
J Am Stat Assoc. 2021;116(534):531-545. doi: 10.1080/01621459.2020.1799809. Epub 2020 Jul 28.

Genetics plays a role in age-related macular degeneration (AMD), a common cause of blindness in the elderly. There is a need for powerful methods for carrying out region-based association tests between a dichotomous trait like AMD and genetic variants...

Many-Body Chaos in the Sachdev-Ye-Kitaev Model.

Physical review letters

Kobrin B, Yang Z, Kahanamoku-Meyer GD, Olund CT, Moore JE, Stanford D, Yao NY.
PMID: 33543957
Phys Rev Lett. 2021 Jan 22;126(3):030602. doi: 10.1103/PhysRevLett.126.030602.

Many-body chaos has emerged as a powerful framework for understanding thermalization in strongly interacting quantum systems. While recent analytic advances have sharpened our intuition for many-body chaos in certain large N theories, it has proven challenging to develop precise...

Insular cortex neurons encode and retrieve specific immune responses.

Cell

Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan TL, Azulay-Debby H, Zalayat I, Avishai E, Hajjo H, Schiller M, Haykin H, Korin B, Farfara D, Hakim F, Kobiler O, Rosenblum K, Rolls A.
PMID: 34890554
Cell. 2021 Dec 09;184(25):6211. doi: 10.1016/j.cell.2021.11.021.

No abstract available.

The National Cancer Institute's Role in Advancing Health-Care Delivery Research.

Journal of the National Cancer Institute

Jacobsen PB, de Moor J, Doria-Rose VP, Geiger AM, Kobrin SC, Sampson A, Smith AW.
PMID: 33993284
J Natl Cancer Inst. 2022 Jan 11;114(1):20-24. doi: 10.1093/jnci/djab096.

Improvements in cancer care delivery have the potential to reduce morbidity and mortality from cancer, however, challenges to delivery of recommended care limit progress. These challenges include growing demands for care, increasing treatment complexity, inadequate care coordination, dramatic increases...

Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.

Preventive medicine

Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC.
PMID: 34762966
Prev Med. 2021 Nov 08;154:106871. doi: 10.1016/j.ypmed.2021.106871. Epub 2021 Nov 08.

Since 2012, cervical cancer screening guidelines allow for choice of screening test for women age 30-65 years (i.e., Pap every 3 years or Pap with human papillomavirus co-testing every 5 years). Intended to give patients and providers options, this...

Showing 73 to 80 of 80 entries